BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22246403)

  • 1. The N-terminally truncated p53 isoform Δ40p53 influences prognosis in mucinous ovarian cancer.
    Hofstetter G; Berger A; Berger R; Zorić A; Braicu EI; Reimer D; Fiegl H; Marth C; Zeimet AG; Ulmer H; Moll U; Zeillinger R; Concin N
    Int J Gynecol Cancer; 2012 Mar; 22(3):372-9. PubMed ID: 22246403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.
    Hofstetter G; Berger A; Schuster E; Wolf A; Hager G; Vergote I; Cadron I; Sehouli J; Braicu EI; Mahner S; Speiser P; Marth C; Zeimet AG; Ulmer H; Zeillinger R; Concin N
    Br J Cancer; 2011 Nov; 105(10):1593-9. PubMed ID: 22009029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
    Oh L; Hainaut P; Blanchet S; Ariffin H
    BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer].
    Coronado Martín PJ; Fasero Laiz M; García Santos J; Ramírez Mena M; Vidart Aragón JA
    Med Clin (Barc); 2007 Jan; 128(1):1-6. PubMed ID: 17266884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the QuantiGene 2.0 Assay and Real-Time RT-PCR in the Detection of p53 Isoform mRNA Expression in Formalin-Fixed Paraffin-Embedded Tissues- A Preliminary Study.
    Morten BC; Scott RJ; Avery-Kiejda KA
    PLoS One; 2016; 11(11):e0165930. PubMed ID: 27832134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion.
    Zhang X; Groen K; Morten BC; Steffens Reinhardt L; Campbell HG; Braithwaite AW; Bourdon JC; Avery-Kiejda KA
    Mol Oncol; 2022 Jan; 16(2):447-465. PubMed ID: 34657382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma.
    Bischof K; Knappskog S; Stefansson I; McCormack EM; Trovik J; Werner HMJ; Woie K; Gjertsen BT; Bjorge L
    BMC Cancer; 2018 Jun; 18(1):684. PubMed ID: 29940909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of p53 isoform expression in serous ovarian cancer.
    Chambers SK; Martinez JD
    Future Oncol; 2012 Jun; 8(6):683-6. PubMed ID: 22764765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.
    Bischof K; Knappskog S; Hjelle SM; Stefansson I; Woie K; Salvesen HB; Gjertsen BT; Bjorge L
    Sci Rep; 2019 Mar; 9(1):5244. PubMed ID: 30918304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer.
    Hofstetter G; Berger A; Fiegl H; Slade N; Zorić A; Holzer B; Schuster E; Mobus VJ; Reimer D; Daxenbichler G; Marth C; Zeimet AG; Concin N; Zeillinger R
    Oncogene; 2010 Apr; 29(13):1997-2004. PubMed ID: 20101229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Δ40p53 isoform on enhancing the pro-apoptotic function of p53 in tumor cells].
    Wang BS; Zhao HW; Qiao LX; Shan JQ; Hou QS; Chen DX; Guo HL
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):332-338. PubMed ID: 28535648
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucinous tumors of the ovary: current thoughts on diagnosis and management.
    Brown J; Frumovitz M
    Curr Oncol Rep; 2014 Jun; 16(6):389. PubMed ID: 24777667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells.
    Melo Dos Santos N; de Oliveira GAP; Ramos Rocha M; Pedrote MM; Diniz da Silva Ferretti G; Pereira Rangel L; Morgado-Diaz JA; Silva JL; Rodrigues Pereira Gimba E
    J Biol Chem; 2019 Jun; 294(24):9430-9439. PubMed ID: 31028175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the interactions of HPV-16 E6*I and E6*II with p53 isoforms and induction of apoptosis in cancer-derived cell lines.
    Antonio-Véjar V; Ortiz-Sánchez E; Rosendo-Chalma P; Patiño-Morales CC; Guido-Jiménez MC; Alvarado-Ortiz E; Hernández G; García-Carrancá A
    Pathol Res Pract; 2022 Jun; 234():153890. PubMed ID: 35487028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
    Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
    [No Abstract]   [Full Text] [Related]  

  • 17. The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.
    Avery-Kiejda KA; Morten B; Wong-Brown MW; Mathe A; Scott RJ
    Carcinogenesis; 2014 Mar; 35(3):586-96. PubMed ID: 24336193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort.
    Groen K; Steffens Reinhardt L; Bourdon JC; Avery-Kiejda KA
    Cancer Cell Int; 2023 Oct; 23(1):228. PubMed ID: 37794430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble isoforms but not the transmembrane form of coxsackie-adenovirus receptor are of clinical relevance in epithelial ovarian cancer.
    Reimer D; Steppan I; Wiedemair A; Concin N; Hofstetter G; Marth C; Müller-Holzner E; Zeimet AG
    Int J Cancer; 2007 Jun; 120(12):2568-75. PubMed ID: 17278108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant effects of Δ40p53 on p53 function and melanoma cell fate.
    Takahashi R; Markovic SN; Scrable HJ
    J Invest Dermatol; 2014 Mar; 134(3):791-800. PubMed ID: 24037342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.